Connection

RAJKUMAR VENKATRAMANI to Rhabdomyosarcoma, Embryonal

This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Rhabdomyosarcoma, Embryonal.
  1. Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy. Cancer. 2022 12 01; 128(23):4150-4156.
    View in: PubMed
    Score: 0.788
  2. An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials. Pediatr Blood Cancer. 2022 04; 69(4):e29511.
    View in: PubMed
    Score: 0.751
  3. Comment on: Patients with nonmetastatic embryonal rhabdomyosarcoma arising in the biliary tract should be treated on low-risk clinical trials. Pediatr Blood Cancer. 2022 07; 69(7):e29554.
    View in: PubMed
    Score: 0.745
  4. Congenital spindle cell rhabdomyosarcoma. Pediatr Blood Cancer. 2019 11; 66(11):e27935.
    View in: PubMed
    Score: 0.630
  5. Insulin-like Growth Factor 2 Gene Expression Molecularly Differentiates Pleuropulmonary Blastoma and Embryonal Rhabdomyosarcoma. J Pediatr Hematol Oncol. 2015 Aug; 37(6):e356-60.
    View in: PubMed
    Score: 0.478
  6. Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer. 2024 Apr; 71(4):e30847.
    View in: PubMed
    Score: 0.215
  7. Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis. Cancer Med. 2023 05; 12(9):10222-10229.
    View in: PubMed
    Score: 0.203
  8. Rhabdomyosarcoma with isolated lung metastases: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer. 2023 06; 70(6):e30293.
    View in: PubMed
    Score: 0.203
  9. Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001-2017. Cancer Med. 2023 02; 12(3):3644-3656.
    View in: PubMed
    Score: 0.195
  10. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe. Eur J Cancer. 2022 09; 172:367-386.
    View in: PubMed
    Score: 0.193
  11. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis. Eur J Cancer. 2022 06; 168:56-64.
    View in: PubMed
    Score: 0.190
  12. Deep Learning of Rhabdomyosarcoma Pathology Images for Classification and Survival Outcome Prediction. Am J Pathol. 2022 06; 192(6):917-925.
    View in: PubMed
    Score: 0.190
  13. Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group. Pediatr Blood Cancer. 2022 06; 69(6):e29644.
    View in: PubMed
    Score: 0.189
  14. Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2021 01 15; 127(2):275-283.
    View in: PubMed
    Score: 0.172
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.